Bio-Techne Corp. | Ownership

Companies that own Bio-Techne Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
3,499,465
9.27%
39,496
0.03%
06/30/2018
The Vanguard Group, Inc.
3,262,952
8.65%
82,506
0.02%
06/30/2018
Brown Capital Management LLC
1,980,782
5.25%
-8,779
3.36%
06/30/2018
Atlanta Capital Management Co. LLC
1,904,079
5.05%
-14,977
1.7%
06/30/2018
Neuberger Berman Investment Advisers LLC
1,584,254
4.2%
-61,253
0.32%
06/30/2018
BAMCO, Inc.
1,510,434
4%
-9,889
1.01%
06/30/2018
Henderson Global Investors Ltd.
1,393,027
3.69%
76,538
0.12%
06/30/2018
Mairs & Power, Inc.
1,338,613
3.55%
-87,590
2.73%
06/30/2018
Jackson Square Partners LLC
994,196
2.64%
84,674
0.7%
06/30/2018
SSgA Funds Management, Inc.
943,309
2.5%
-48,405
0.01%
06/30/2018

About Bio-Techne

View Profile
Address
614 McKinley Place NE
Minneapolis Minnesota 55413
United States
Employees -
Website http://www.bio-techne.com
Updated 07/08/2019
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community.